Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Mylan nets $2.8bn through follow-on offerings

Executive Summary

Mylan completed two follow-on public offerings, netting about $2.8bn. In the first, the company sold 2.14mm of its 6.5% convertible preferred shares (including the overallotment) at $1k apiece; the shares convert into common in three years at between $58.55 and $71.43 each. The second transaction consisted of the sale of 55.4mm common shares (including partial exercise of the overallotment) at $14 apiece.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies